Effect of Cold Shower Therapy on Hot Flashes And Night Sweats in Menopausal Women

July 6, 2026 updated by: Beyza AYDIN ATALAY, Istanbul University - Cerrahpasa

Effect of Cold Shower Therapy on Hot Flashes and Night Sweats in Menopausal Women

This randomized controlled trial aims to evaluate the effect of a 6-week cold shower therapy on hot flashes and night sweats in menopausal women. Participants will be randomly assigned to either a cold shower therapy group or a control group. The primary outcome is the change in the frequency and severity of hot flashes and night sweats after the 6-week intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Menopausal hot flashes and night sweats are common vasomotor symptoms that negatively affect quality of life. This randomized controlled trial investigates the effectiveness of a 6-week cold shower therapy as a non-pharmacological intervention for reducing these symptoms. Eligible menopausal women will be randomly assigned to an intervention group or a control group. The intervention group will receive cold shower therapy for six weeks, while the control group will receive routine care. Outcomes will be assessed before and after the intervention using validated measurement tools. The study aims to determine whether cold shower therapy is an effective, safe, and low-cost method for managing menopausal vasomotor symptoms.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Istanbul
      • Istanbul, Istanbul, Turkey (Türkiye)
        • Buyukada Central Family Health Center, Unit 001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Able to read, write, and understand the study procedures.
  • Women aged 40-65 years.
  • Postmenopausal women experiencing hot flashes and/or night sweats.
  • Not receiving hormone replacement therapy (HRT) for vasomotor symptoms.
  • No known medical contraindication to cold shower therapy.
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria:

  • History of serious chronic diseases that may affect hemodynamic stability (e.g., cardiovascular disease, uncontrolled hypertension, renal failure, or liver failure).
  • Current use of antidepressant or antipsychotic medications, or diagnosis of a severe psychiatric disorder.
  • Regular use of cold shower or cold-water therapy before enrollment.
  • Incomplete completion of study questionnaires or data collection forms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cold Shower Therapy
Participants received cold shower therapy for 6 weeks.
Behavioral: Cold Shower Therapy
Participants in the intervention group received daily cold shower therapy for 6 weeks. Water temperature was maintained at 15-20°C using a thermometer provided to participants. The control group received routine care without cold shower therapy. Outcomes were assessed at baseline and after 6 weeks.
No Intervention: Control
Participants received routine care and no cold shower therapy during the study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hot Flash and Night Sweat Frequency and Severity
Time Frame: Baseline, Week 3, Week 6
Change in the frequency and severity of hot flashes and night sweats measured at baseline, week 3 and week 6.
Baseline, Week 3, Week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul University - Cerrahpasa

Investigators

  • Principal Investigator: Nuran Gencturk, PhD, Istanbul University - Cerrahpasa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2026

Primary Completion (Actual)

July 7, 2026

Study Completion (Actual)

July 7, 2026

Study Registration Dates

First Submitted

July 6, 2026

First Submitted That Met QC Criteria

July 6, 2026

First Posted (Actual)

July 10, 2026

Study Record Updates

Last Update Posted (Actual)

July 10, 2026

Last Update Submitted That Met QC Criteria

July 6, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BAA-2026-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hot Flashes

Clinical Trials on Cold Shower Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe